134 related articles for article (PubMed ID: 6343068)
21. Effects of co-administration of butylated hydroxytoluene, butylated hydroxyanisole and flavonoids on the activation of mutagens and drug-metabolizing enzymes in mice.
Sun B; Fukuhara M
Toxicology; 1997 Sep; 122(1-2):61-72. PubMed ID: 9274802
[TBL] [Abstract][Full Text] [Related]
22. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro.
Shearn CT; Fritz KS; Meier BW; Kirichenko OV; Thompson JA
Chem Res Toxicol; 2008 Aug; 21(8):1631-41. PubMed ID: 18597497
[TBL] [Abstract][Full Text] [Related]
23. Butylhydroxytoluene (BHT) increases susceptibility of transgenic rasH2 mice to lung carcinogenesis.
Umemura T; Kodama Y; Hioki K; Inoue T; Nomura T; Kurokawa Y
J Cancer Res Clin Oncol; 2001 Oct; 127(10):583-90. PubMed ID: 11599794
[TBL] [Abstract][Full Text] [Related]
24. Synthetic antioxidants: biochemical actions and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens.
Kahl R
Toxicology; 1984 Dec; 33(3-4):185-228. PubMed ID: 6393452
[TBL] [Abstract][Full Text] [Related]
25. Decrease in the protein kinase C-catalyzed phosphorylation of an endogenous lung protein (Mr 36,000) following treatment of mice with the tumor-modulatory agent butylated hydroxytoluene.
Malkinson AM; Beer DS; Sadler AJ; Coffman DS
Cancer Res; 1985 Nov; 45(11 Pt 2):5751-6. PubMed ID: 4053047
[TBL] [Abstract][Full Text] [Related]
26. A metabolite of butylated hydroxytoluene with potent tumor-promoting activity in mouse lung.
Thompson JA; Schullek KM; Fernandez CA; Malkinson AM
Carcinogenesis; 1989 Apr; 10(4):773-5. PubMed ID: 2702725
[TBL] [Abstract][Full Text] [Related]
27. Enhanced tumour development by butylated hydroxytoluene (BHT) in the liver, lung and gastro-intestinal tract.
Witschi HP
Food Chem Toxicol; 1986; 24(10-11):1127-30. PubMed ID: 3804115
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation.
Malkinson AM; Beer DS
J Natl Cancer Inst; 1984 Oct; 73(4):925-33. PubMed ID: 6592388
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effect of low- and high-dose dietary butylated hydroxytoluene on microsome-mediated aflatoxin B1-DNA binding.
Allameh A
Cancer Lett; 1997 Mar; 114(1-2):217-20. PubMed ID: 9103296
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
Guarisco JA; Hall JO; Coulombe RA
Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of chemically induced mammary carcinogenesis in rats by long-term exposure to butylated hydroxytoluene (BHT): interrelations among BHT concentration, carcinogen dose, and diet.
Cohen LA; Choi K; Numoto S; Reddy M; Berke B; Weisburger JH
J Natl Cancer Inst; 1986 Apr; 76(4):721-30. PubMed ID: 3083149
[TBL] [Abstract][Full Text] [Related]
32. Responses of tumorigenic and non-tumorigenic mouse lung epithelial cell lines to electrophilic metabolites of the tumor promoter butylated hydroxytoluene.
Sun Y; Dwyer-Nield LD; Malkinson AM; Zhang YL; Thompson JA
Chem Biol Interact; 2003 Mar; 145(1):41-51. PubMed ID: 12606153
[TBL] [Abstract][Full Text] [Related]
33. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.
Williams GM; Tanaka T; Maeura Y
Carcinogenesis; 1986 Jul; 7(7):1043-50. PubMed ID: 2872975
[TBL] [Abstract][Full Text] [Related]
34. In vitro system for detecting non-genotoxic carcinogens.
Dertinger SD; Torous DK; Tometsko AM
Environ Mol Mutagen; 1993; 21(4):332-8. PubMed ID: 8491212
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity.
Soni KB; Lahiri M; Chackradeo P; Bhide SV; Kuttan R
Cancer Lett; 1997 May; 115(2):129-33. PubMed ID: 9149115
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats.
Cha YN; Heine HS
Cancer Res; 1982 Jul; 42(7):2609-15. PubMed ID: 6805943
[TBL] [Abstract][Full Text] [Related]
37. Effects of the butylated hydroxyanisole and butylated hydroxytoluene on the DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumor cells.
Chang SH; Chen GW; Yeh CC; Hung CF; Lin SS; Chung JG
Anticancer Res; 2001; 21(2A):1087-93. PubMed ID: 11396144
[TBL] [Abstract][Full Text] [Related]
38. In vivo protective role of antioxidants against genotoxicity of metronidazole and azanidazole.
Hrelia P; Murelli L; Paolini M; Cantelli-Forti G
Drugs Exp Clin Res; 1987; 13(9):577-83. PubMed ID: 3322753
[TBL] [Abstract][Full Text] [Related]
39. Report of ICPEMC Task Group 5 on the differentiation between genotoxic and non-genotoxic carcinogens.
Mutat Res; 1984 Jan; 133(1):1-49. PubMed ID: 6363908
[No Abstract] [Full Text] [Related]
40. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat.
Chung JG
Toxicol Sci; 1999 Oct; 51(2):202-10. PubMed ID: 10543022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
